Search results - 3 results
Annual Report Belgian Cystic Fibrosis Registry 2018
xylosoxidans from 5.9% in 2009, stabilizing at prevalence levels of about 10.0% since 2012. The prevalence of the Burkholderia cepacia complex on the other hand has decreased to 3.0% in 2018, after a stable ...
Annual Report Belgian Cystic Fibrosis Registry 2017
levels above 10.0% since 2012, but reaching 11.4% in 2017. The prevalence of the Burkholderia cepacia complex on the other hand has decreased to 2.9%, after a stable period at 3.5% over the years since ...
The burden of cystic fibrosis in Belgium: a registry-based study
substantial distress on patient level. However, the specific impact on individual health as well as the national impact on public health remains to be elucidated. The aim of this dissertation is to quantify and ...